CSIMarket
 

The Cigna Group  (NYSE: CI)

The Cigna Group's

Competitiveness




 

CI Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, The Cigna Group reported Revenue increase in the 1 quarter 2026 by 4.57 % year on year.
The revenue growth was below The Cigna Group's competitors' average revenue growth of 5.39 %, achieved in the same quarter.

List of CI Competitors

With a net margin of 2.72 % The Cigna Group reported lower profitability than its competitors.

More on CI Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


The Cigna Group Net Income in the 1 quarter 2026 grew year on year by 32.08%, slower than its competitors' income growth of 42.96 %

<<  CI Stock Performance Comparisons


The Cigna Group's Comment on Competition and Industry Peers


The competitive landscape encompasses a range of entities including independent and managed care pharmacy benefit managers; retail, home delivery, and specialty pharmacies; specialty drug distributors; health plans; third-party benefit administrators; group purchasing organizations; clinical solutions companies; health care data analytics firms; care services providers; national and local insurers; third-party administrators; dental insurers; global insurers; and local non-U.S. insurers. Key competitive factors involve negotiating pharmacy networks, providing specialty pharmacy services, managing drug costs and quality, claim adjudication, benefit administration, enhancing healthcare access and outcomes, delivering primary and behavioral care, navigating government-reimbursed business, quality of care, cost-effectiveness, medical care management, product offerings, total cost management, technology, marketing and sales effectiveness, and financial strength as rated by nationally recognized agencies. Cigna Healthcare is identified as offering individual ACA-compliant policies through public health insurance exchanges in select geographic areas.



  

Overall company Market Share Q1 2026

Overall company revenue, grew less, than total company revenues, at 4.57 % and company approximately market share, declined to 8.92 %.
<<  More on CI Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of The Cigna Group




Futu Holdings Ltd
Share Performance



+19.65%
This Quarter



Futu Holdings Ltd
Profile

Futu Holdings Ltd operates as an online brokerage and wealth management platform in China and globally. The company provides technology-driven brokerage and wealth management services to retail investors, offering trading services for stocks, options, and mutual funds, among others. Additionally, Futu Holdings also generates revenue through interest income from its margin financing and securities lending services.

More about Futu Holdings Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 137,974.606 mill. $ 2,935.374 mill. $ 1,452.070 mill.


Aon Plc
Share Performance



-9.16%
30 Days



Aon Plc
Profile

Aon Plc operates as a professional services firm that delivers comprehensive risk, retirement, and health solutions, tailoring its offerings to meet the unique needs of its clients. By leveraging data analytics and industry expertise, Aon enhances decision-making, helping businesses effectively manage risks while optimizing their operational performance.

More about Aon Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 69,945.300 mill. $ 17,603.000 mill. $ 3,978.000 mill.


Aspira Women s Health inc
Share Performance



-34.78%
One Year



Aspira Women s Health inc
Profile

Aspira Women’s Health develops AI-powered noninvasive diagnostic tests for gynecologic diseases.

More about Aspira Women s Health inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13.275 mill. $ 9.029 mill. $ -10.005 mill.


Axis Capital Holdings Limited
Share Performance



-2.73%
30 Days



Axis Capital Holdings Limited
Profile

Axis Capital Holdings Ltd operates as a global provider of specialty insurance and reinsurance products. They offer coverage for various industries including property, casualty, marine, energy, aviation, and more. The company follows a diversified business model to manage risks and generate profitable underwriting results while maintaining a strong balance sheet and delivering value to its shareholders.

More about Axis Capital Holdings Limited's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 7,620.514 mill. $ 6,685.203 mill. $ 1,069.594 mill.


Berkshire Hathaway Inc
Share Performance



+0.94%
Over The Past 5 Days



Berkshire Hathaway Inc
Profile

Berkshire Hathaway Inc's business model is primarily focused on investing in diverse companies across various industries.

More about Berkshire Hathaway Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 384,687.000 mill. $ 86,082.000 mill.

61 more competitors available

Sign in to see all competitors

Sources: The Cigna Group’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on The Cigna Group versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.